HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Frederico B Sousa Selected Research

Lipids

5/2014Cross talk between angiotensin-(1-7)/Mas axis and sirtuins in adipose tissue and metabolism of high-fat feed mice.
8/2013Oral Angiotensin-(1-7) prevented obesity and hepatic inflammation by inhibition of resistin/TLR4/MAPK/NF-κB in rats fed with high-fat diet.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Frederico B Sousa Research Topics

Disease

2Insulin Resistance
05/2014 - 08/2013
2Inflammation (Inflammations)
08/2013 - 08/2013
1Ischemic Stroke
01/2018
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2018
1Cerebral Infarction
01/2018
1Stroke (Strokes)
01/2018
1Obesity
08/2013
1Body Weight (Weight, Body)
08/2013
1Necrosis
08/2013
1Myocardial Infarction
03/2011
1Cardiomegaly (Heart Hypertrophy)
03/2011
1Infarction (Infarctions)
03/2011

Drug/Important Bio-Agent (IBA)

3angiotensin I (1-7)IBA
01/2018 - 08/2013
2Glucose (Dextrose)FDA LinkGeneric
05/2014 - 08/2013
2LipidsIBA
05/2014 - 08/2013
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
01/2018
1CyclodextrinsIBA
01/2018
1Neuroprotective AgentsIBA
01/2018
1Tissue Plasminogen Activator (Alteplase)FDA Link
01/2018
1Aspartic Acid (Aspartate)FDA Link
08/2013
1CholesterolIBA
08/2013
1Insulin (Novolin)FDA Link
08/2013
1Triglycerides (Triacylglycerol)IBA
08/2013
1Tumor Biomarkers (Tumor Markers)IBA
08/2013
1Interleukin-6 (Interleukin 6)IBA
08/2013
1Transaminases (Aminotransferases)IBA
08/2013
1ResistinIBA
08/2013
1Isoproterenol (Isoprenaline)FDA LinkGeneric
03/2011
1Hematoxylin (Haematoxylon)IBA
03/2011
1Eosine Yellowish-(YS) (Eosin)IBA
03/2011

Therapy/Procedure

2Oral Administration
01/2018 - 03/2011
1Therapeutics
01/2018